Company Description
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.
This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics.
Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry.
The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023.
Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
| Country | United States |
| Founded | 2001 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 46,000 |
| CEO | Robert Mauch |
Contact Details
Address: 1 West First Avenue Conshohocken, Pennsylvania 19428-1800 United States | |
| Phone | 610 727 7000 |
| Website | cencora.com |
Stock Details
| Ticker Symbol | COR |
| Exchange | NYSE |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001140859 |
| CUSIP Number | 03090BBJ8 |
| ISIN Number | US03073E1055 |
| Employer ID | 23-3079390 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Dr. Robert P. Mauch Ph.D., PharmD | President, Chief Executive Officer, Chief Operating Officer, Executive Vice President and Director |
| Steven H. Collis | Executive Chairman |
| James F. Cleary Jr. | Executive Vice President and Chief Financial Officer |
| Elizabeth S. Campbell J.D. | Executive Vice President and Chief Legal Officer |
| Lazarus Krikorian | Senior Vice President, Chief Accounting Officer and Corporate Controller |
| Pawan Singh Verma | Executive Vice President, Chief Data and Information Officer |
| Bennett S. Murphy | Senior Vice President of Investor Relations |
| Jennifer E. Dubas | Senior Vice President and Chief Compliance Officer |
| Silvana Battaglia | Executive Vice President and Chief Human Resources Officer |
| Richard Tremonte | Executive Vice President and President of U.S. Pharmaceuticals |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 20, 2024 | 144 | Filing |
| Dec 10, 2024 | 8-K | Current Report |
| Dec 4, 2024 | 424B2 | Prospectus |
| Dec 4, 2024 | 8-K | Current Report |
| Dec 3, 2024 | 144 | Filing |
| Dec 2, 2024 | FWP | Free Writing Prospectus |
| Dec 2, 2024 | 424B5 | Filing |
| Nov 27, 2024 | 8-K | Current Report |
| Nov 26, 2024 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers |
| Nov 26, 2024 | 10-K | Annual Report |